Recently, the PI3K/AKT pathway has been shown to exert a pivotal role in regulating anti-tumor immunity by promoting an immunosuppressive TME and controlling the activity of the tumor infiltration cells associated [151]. The gene discussed is AKT1; the disease is neoplasm.